In addition, we performed in silico analysis using an online TCGA database (http://www.oncolnc.org) and found that breast cancer patients with high DNMT3B mRNA expression had a lower survival rate than patients with low DNMT3B mRNA expression (Fig. 3e). This evidence concerns the gene DNMT3B and breast cancer.